Ā | Non-floating | Postoperative floating | p value |
---|---|---|---|
Age (years) | 61.4 (10.1) | 62.2 (6.5) | 0.76 |
Sex | |||
āMale (%) | 0 (0%) | 0 (0%) | Ā |
āFemale (%) | 22 (100%) | 25 (100%) | Ā |
BMI | 21.3 (4.1) | 20.5 (3.2) | 0.45 |
Clinical follow-up (months) | 36.0 (29.0) | 36.9 (28.0) | 0.92 |
Duration of disease (years) | 17.8 (8.9) | 22.6 (10.7) | 0.12 |
CRP (mg/dl) | 0.52 (1.1) | 0.26 (0.2) | 0.40 |
MMP-3 (ng/ml) | 130.7 (88.9) | 100.4 (82.2) | 0.42 |
DAS28-CRP | 3.40 (1.6) | 3.27 (1.5) | 0.89 |
bDMARD use (%) | 11 (50%) | 6 (24%) | 0.06 |
MTX user (%) | 15 (68%) | 15 (60%) | 0.56 |
PSL user (%) | 19 (86%) | 15 (60%) | 0.13 |
Total arc of first MTP joint(Ā°) | 23.9 (19.2) | 26.3 (16.2) | 0.35 |